Skip to main content

Articles

Page 1 of 74

  1. The relationship between sarcopenia and chronic obstructive pulmonary disease (COPD) has been increasingly reported, and there is some overlap regarding their clinical features and pulmonary rehabilitation (PR...

    Authors: Sang Hun Kim, Cho Hui Hong, Myung-Jun Shin, Ki Uk Kim, Tae Sung Park, Jun Yong Park and Yong Beom Shin
    Citation: BMC Pulmonary Medicine 2024 24:219
  2. Utilizing clinical tests, such as objective cough measurement, can assist in predicting the success of the weaning process in critically ill patients.

    Authors: Fabio Varón-Vega, Adriana Rincón, Luis F. Giraldo-Cadavid, Eduardo Tuta-Quintero, Jonathan Palacios, Stephanie Crevoisier, Diana C. Duarte, Marcela Poveda, Laura Cucunubo and Pablo Monedero
    Citation: BMC Pulmonary Medicine 2024 24:218
  3. The effectiveness of high-flow nasal cannula (HFNC) therapy in patients with bronchiectasis experiencing hypercapnia remains unclear. Our aim was to retrospectively analyze the short-term outcomes of HFNC ther...

    Authors: Jing Yang, Lei Chen, Hang Yu, Jingjing Hu and Feng Qiu
    Citation: BMC Pulmonary Medicine 2024 24:217
  4. High-flow nasal cannula (HFNC) is often used in pediatric populations with respiratory distress. In adults, the respiratory-rate oxygenation (ROX) index is used as a predictor of HFNC therapy; however, childre...

    Authors: Irene Yuniar, Antonius Hocky Pudjiadi, Rismala Dewi, Yogi Prawira, Niken Wahyu Puspaningtyas, Tartila Tartila and Sharfina Fulki
    Citation: BMC Pulmonary Medicine 2024 24:216
  5. Pulmonary rehabilitation (PR) is recommended for the treatment of people with idiopathic pulmonary fibrosis (IPF). Physical activity is an important health behaviour, closely linked to survival in people with ...

    Authors: Orlagh O’Shea, Grainne Murphy, Lynn Fox and Katherine M.A. O’Reilly
    Citation: BMC Pulmonary Medicine 2024 24:215
  6. In western Yokohama, our hospital and primary care clinics manage adults with asthma via a coordinated care system. We investigated the changes in the fractional expired nitric oxide (FeNO), forced expiratory ...

    Authors: Takahiro Tsuburai, Satoshi Tanaka, Yuko Komase, Baku Oyama, Hiromi Muraoka, Yusuke Shinozaki, Kazuhiro Nishiyama, Junko Ueno Shibuya, Yoshihiro Nishi, Yu Numata, Naoya Hida, Masamichi Mineshita and Takeo Inoue
    Citation: BMC Pulmonary Medicine 2024 24:214
  7. Ventilator-associated pneumonia (VAP) presents a significant challenge in intensive care units (ICUs). Nebulized antibiotics, particularly colistin and tobramycin, are commonly prescribed for VAP patients. How...

    Authors: Jefferson Antonio Buendía, Diana Guerrero Patiño and Andrés Felipe Zuluaga Salazar
    Citation: BMC Pulmonary Medicine 2024 24:213
  8. Patient-ventilator asynchrony commonly occurs during pressure support ventilation (PSV). IntelliSync + software (Hamilton Medical AG, Bonaduz, Switzerland) is a new ventilation technology that continuously ana...

    Authors: Barnpot Nakornnoi, Jamsak Tscheikuna and Nuttapol Rittayamai
    Citation: BMC Pulmonary Medicine 2024 24:212
  9. Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc). An important component of SSc patient management is early detection and treatment of PH. Recently the threshol...

    Authors: Matthew R. Lammi, Monica Mukherjee, Lesley Ann Saketkoo, Kyle Carey, Laura Hummers, Steven Hsu, Amita Krishnan, Marie Sandi, Ami A. Shah, Stefan L. Zimmerman, Paul M. Hassoun and Steven C. Mathai
    Citation: BMC Pulmonary Medicine 2024 24:211
  10. Measurement of exhaled nitric oxide (FeNO) is a potentially useful diagnostic test for asthma. However, no study has explored the relationship between FeNO and respiratory symptoms of nontuberculous mycobacter...

    Authors: Mari Miki, Keisuke Miki, Eri Akiba, Hiroyuki Kagawa, Yohei Oshitani, Takanori Matsuki, Kazuyuki Tsujino, Seigo Kitada, Ryoji Maekura and Hiroshi Kida
    Citation: BMC Pulmonary Medicine 2024 24:210
  11. The pathogenesis of adult non-cystic fibrosis (CF) bronchiectasis is complex, and the relevant molecular mechanism remains ambiguous. Versican (VCAN) is a key factor in inflammation through interactions with a...

    Authors: Wan-Ying Huang, Kang-Kang Hong, Rong-Quan He, Jing Luo, Zhi-Guang Huang, Chu-Yue Zhang, Yang Xu, Chong-Xi Bao, Liang-Ming Zhang, Gang Chen and Jin-Liang Kong
    Citation: BMC Pulmonary Medicine 2024 24:209
  12. Coronavirus disease 2019 (COVID-19) has been proved as a significant risk factor for deep vein thrombosis (DVT) after several waves of pandemic. This study aims to further investigate impact of COVID-19 on pro...

    Authors: Qi Wang, Jiajun Wu, Pengfei Zhang and Xu Ma
    Citation: BMC Pulmonary Medicine 2024 24:208
  13. The aim of this research was to examine how penehyclidine hydrochloride (PHC) impacts the occurrence of pyroptosis in lung tissue cells within a rat model of lung ischemia-reperfusion injury.

    Authors: Rongfang Liu, Xuguang Zhang, Jing Yan, Shan Liu, Yongle Li, Guangyi Wu and Jingui Gao
    Citation: BMC Pulmonary Medicine 2024 24:207
  14. The Corona Virus Disease 2019 (COVID-19) pandemic has struck globally. Whether the related proteins of retinoic acid (RA) signaling pathway are causally associated with the risk of COVID-19 remains unestablish...

    Authors: Haixia Wang, Zhiyun Zhang, Li Xie, Kongli Lu, Shuyi Zhang and Shunpeng Xing
    Citation: BMC Pulmonary Medicine 2024 24:206
  15. Pneumocystis jirovecii pneumonia (PJP) is an interstitial pneumonia caused by pneumocystis jirovecii (PJ). The diagnosis of PJP primarily relies on the detection of the pathogen from lower respiratory tract speci...

    Authors: Yingying Li, Hailin Liu, Qingwen Lv and Jun Long
    Citation: BMC Pulmonary Medicine 2024 24:205
  16. Bronchial arterial embolization (BAE) has been accepted as an effective treatment for bronchiectasis-related hemoptysis. However, rare clinical trials compare different sizes of specific embolic agents. This s...

    Authors: Hong-Dou Xu, Liang Yang and Shi-Bing Hu
    Citation: BMC Pulmonary Medicine 2024 24:203
  17. Interstitial lung disease (ILD) represents a heterogeneous group of lung disorders characterized by fibrotic lung tissue changes. In regions with severe donor shortages, single-lung transplantation (SLTx) is o...

    Authors: Toshikazu Watanabe, Takashi Hirama, Ken Onodera, Hirotsugu Notsuda, Hisashi Oishi, Hiromichi Niikawa, Kazuyoshi Imaizumi and Yoshinori Okada
    Citation: BMC Pulmonary Medicine 2024 24:202
  18. To summarize and analyze the safety and efficacy of a Y-shape Sigma stent loaded with I125 in patients with inoperable malignant main airway obstruction.

    Authors: Chunlong Lin, Hesong Huang, Lixia Song, Xixi Zhao, Jialing Zeng, Lun Li, Qilong Ge, Rui Li and Zhiyuan Wu
    Citation: BMC Pulmonary Medicine 2024 24:201
  19. Interstitial lung abnormalities (ILAs) on CT may affect the clinical outcomes in patients with chronic obstructive pulmonary disease (COPD), but their quantification remains unestablished. This study examined ...

    Authors: Yusuke Shiraishi, Naoya Tanabe, Ryo Sakamoto, Tomoki Maetani, Shizuo Kaji, Hiroshi Shima, Satoru Terada, Kunihiko Terada, Kohei Ikezoe, Kiminobu Tanizawa, Tsuyoshi Oguma, Tomohiro Handa, Susumu Sato, Shigeo Muro and Toyohiro Hirai
    Citation: BMC Pulmonary Medicine 2024 24:200
  20. Fractional exhaled nitric oxide (FeNO) has been extensively studied in various causes of pulmonary hypertension (PH), but its utility as a noninvasive marker remains highly debated. The objective of our study ...

    Authors: Jianhua Xu, Xingxing Sun, Yuan Cao, Hanqing Zhu, Wenlan Yang, Jinming Liu and Jian Guo
    Citation: BMC Pulmonary Medicine 2024 24:199
  21. Iopamidol is a non-ionic, water-soluble iodine contrast agent that is considered safe for intravenous or intra-arterial administration and is widely used both in the general population and in patients undergoi...

    Authors: Weixian Xu, Miaozhen Chen, Songtao Liu, Yi Su and Yunhai Zhang
    Citation: BMC Pulmonary Medicine 2024 24:198
  22. High-flow nasal cannula (HFNC) has emerged as a promising noninvasive method for delivering oxygen to critically ill patients, particularly those with sepsis and acute lung injury. However, uncertainties persi...

    Authors: Lijun Song, Min Li, Tianlong Zhang, Lei Huang, Jianjun Ying and Lan Ying
    Citation: BMC Pulmonary Medicine 2024 24:197
  23. Comparisons between endurance training (ET) and resistance training (RT) have produced equivocal findings in chronic obstructive pulmonary disease (COPD) patients. The purpose of our study is to investigate th...

    Authors: Shilei Cui, Haiying Ji, Li Li, Huili Zhu, Xiangyang Li, Ying Gong, Yuanlin Song, Lijuan Hu and Xu Wu
    Citation: BMC Pulmonary Medicine 2024 24:196
  24. Patients with congenital myopathies may experience respiratory involvement, resulting in restrictive ventilatory dysfunction and respiratory failure. Pulmonary hypertension (PH) associated with this condition ...

    Authors: Yinong Chen, Shuai Zhang, Xin Lu, Wanmu Xie, Chen Wang and Zhenguo Zhai
    Citation: BMC Pulmonary Medicine 2024 24:194
  25. Granulomatosis with polyangiitis (GPA) is characterized by necrotizing granulomatous inflammation with necrotizing vasculitis predominantly affecting small to medium vessels. The survival rates have drasticall...

    Authors: Malgorzata Potentas-Policewicz, Malgorzata Szolkowska, Katarzyna Blasinska, Dariusz Gawryluk, Malgorzata Sobiecka and Justyna Fijolek
    Citation: BMC Pulmonary Medicine 2024 24:193
  26. Aspiration pneumoniae remains a major health concern, particularly in the older population and has poor prognosis; however, the concept itself remains vague worldwide. This study aimed to determine the actual ...

    Authors: Iku Tomonaga, Hironobu Koseki, Chieko Imai, Takayuki Shida, Yuta Nishiyama, Daisuke Yoshida, Seiichi Yokoo and Makoto Osaki
    Citation: BMC Pulmonary Medicine 2024 24:191
  27. The Coronavirus disease 2019 (COVID-19) pandemic has robustly affected the global healthcare and economic systems and it was caused by coronavirus-2 (SARS-CoV-2). The clinical presentation of the disease range...

    Authors: Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, Rasha Samir and Mohamed Farouk Allam
    Citation: BMC Pulmonary Medicine 2024 24:190
  28. Nonadherence to therapies and psychological disorders are associated with poor asthma control. This study aims to assess the prevalence of anxiety and depressive symptoms, asthma control, and adherence to inha...

    Authors: Abdullah A. Alqarni, Abdulelah M. Aldhahir, Rayan A. Siraj, Jaber S. Alqahtani, Dana A. Alghamdi, Sarah K. Alghamdi, Abeer A. Alamoudi, Majduleen A. Mohtaseb, Mansour Majrshi, Abdulkareem A. AlGarni, Omaima I. Badr and Hassan Alwafi
    Citation: BMC Pulmonary Medicine 2024 24:189
  29. Dyspnea impairs quality of life (QOL) in patients with fibrotic hypersensitivity pneumonitis (FHP). The Living with Pulmonary Fibrosis questionnaire (L-PF) assesses symptoms, their impacts and PF-related QOL i...

    Authors: Jeffrey J. Swigris, Kerri Aronson and Evans R. Fernández Pérez
    Citation: BMC Pulmonary Medicine 2024 24:188
  30. Coronavirus disease 2019 (COVID-19) has had a global social and economic impact. An easy assessment procedure to handily identify the mortality risk of inpatients is urgently needed in clinical practice. There...

    Authors: Jing Zou, Yiping Shi, Shan Xue and Handong Jiang
    Citation: BMC Pulmonary Medicine 2024 24:187
  31. Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder with systemic consequences that can cause a muscle loss phenotype (MLP), which is characterized by the loss of muscle mass, muscl...

    Authors: Amy H. Attaway, Rocio Lopez, Nicole Welch, Annette Bellar, Umur HatipoÄŸlu, Joe Zein, Marielle PKJ Engelen and Srinivasan Dasarathy
    Citation: BMC Pulmonary Medicine 2024 24:186
  32. Patients with pulmonary arterial hypertension (PAH) exhibit a distinct gut microbiota profile; however, the causal association between gut microbiota, associated metabolites, and PAH remains elusive. We aimed ...

    Authors: Xin Li, Jiang-Shan Tan, Jing Xu, Zhihui Zhao, Qing Zhao, Yi Zhang, Anqi Duan, Zhihua Huang, Sicheng Zhang, Luyang Gao, Yue Jin Yang, Tao Yang, Qi Jin, Qin Luo, Yanmin Yang and Zhihong Liu
    Citation: BMC Pulmonary Medicine 2024 24:185
  33. Chronic obstructive pulmonary disease (COPD) is a frequent cause of morbidity and mortality in the Philippines and majority of the economic burden lies in hospitalizations during an exacerbation. Despite cover...

    Authors: Blake Warren Ang and Lenora Fernandez
    Citation: BMC Pulmonary Medicine 2024 24:184
  34. Despite being a prognostic predictor, cardiac autonomic dysfunction (AD) has not been well investigated in chronic obstructive pulmonary disease (COPD). We aimed to characterise computed tomography (CT), spiro...

    Authors: Minghui Shi, Shiwei Qumu, Siyuan Wang, Yaodie Peng, Lulu Yang, Ke Huang, Ruoxi He, Feng Dong, Hongtao Niu, Ting Yang and Chen Wang
    Citation: BMC Pulmonary Medicine 2024 24:183
  35. Bacterial pneumonia can affect all age groups, but people with weakened immune systems, young children, and the elderly are at a higher risk. Streptococcus pneumoniae, Klebsiella pneumoniae, Haemophilus influenza...

    Authors: Mihret Tilahun, Melaku Ashagrie Belete, Alemu Gedefie, Habtu Debash, Ermiyas Alemayehu, Daniel Gebretsadik, Hussein Ebrahim and Ousman Mohammed
    Citation: BMC Pulmonary Medicine 2024 24:182
  36. Endobronchial ultrasound-guided transbronchial cryobiopsy (EBUS-cryobiopsy) is advantageous for collecting larger specimens with minimal crushing; however, it has not been widely used for mediastinal tumors.

    Authors: Hiroyuki Tsuchida, Yuji Matsumoto, Hideaki Furuse and Takaaki Tsuchida
    Citation: BMC Pulmonary Medicine 2024 24:181
  37. There are currently no data on the relationship between frailty and mortality in pleural disease. Understanding the relationship between frailty and outcomes is increasingly important for clinicians to guide d...

    Authors: Eleanor Barton, A. Verduri, B. Carter, J. Hughes, J. Hewitt and N. A. Maskell
    Citation: BMC Pulmonary Medicine 2024 24:180
  38. Anti-synthetase syndrome (AS) is a rare autoimmune idiopathic inflammatory myopathy (IIM) with diverse manifestations, including arthritis, interstitial lung disease (ILD), Raynaud’s phenomenon, unexplained pe...

    Authors: Xing-Yue Chen, Jun Chen, Li-Jia Zhi, Kun-Lan Long and Pei-Yang Gao
    Citation: BMC Pulmonary Medicine 2024 24:179
  39. Asthma is a common disease characterized by chronic inflammation of the lower airways, bronchial hyperactivity, and (reversible) airway obstruction. The Global Initiative of Asthma Guideline recommends a flowc...

    Authors: T. (Tuba) Kaya, G.J. (Gert-Jan) Braunstahl, J.C.C.M. (Johannes) in ’t Veen, J.H. (Jasper) Kappen and J.P.M. (Hanna) van der Valk
    Citation: BMC Pulmonary Medicine 2024 24:178
  40. Silicosis people are at high risk of developing pulmonary tuberculosis. Whether silica exposure increases the likelihood of latent tuberculosis infection (LTBI) was not well understood, and potential factors i...

    Authors: Xinsong Hu, Cheng Chen, Qianqian Gao, Lang Zhou, Yan Shao, Guoli Li, Honghuan Song, Qiao Liu, Lei Han and Limei Zhu
    Citation: BMC Pulmonary Medicine 2024 24:177
  41. Studies have shown that mitochondrial function and macrophages may play a role in the development of idiopathic pulmonary fibrosis (IPF). However, the understanding of the interactions and specific mechanisms ...

    Authors: Yu Bao, Shiyuan Yang, Hailan Zhao, Yezhen Wang, Ke Li, Xue Liu, Wei Zhang and Xue Zhu
    Citation: BMC Pulmonary Medicine 2024 24:176
  42. Interstitial lung disease (ILD) can lead to lung cancer, which brings great challenges to differential diagnosis and comprehensive treatment. However, the clinical features of lung-dominant connective tissue d...

    Authors: Zi Heng Zhu, Yi Guo, Xiao Yin Wang and Xian Wen Sun
    Citation: BMC Pulmonary Medicine 2024 24:175
  43. Tuberculosis (TB), a highly contagious respiratory disease, presents a significant global health threat, with a notable increase in incidence reported by the WHO in 2022. Particularly, the interplay between TB...

    Authors: Yijiao Xu, Qingwei Zhang, Zhisheng Chen, Shuwen Yang, Haiyan Chen, Xiong Xiao and Hongni Jiang
    Citation: BMC Pulmonary Medicine 2024 24:174
  44. Chronic obstructive pulmonary disease (COPD) induced by smoking poses a significant global health challenge. Recent findings highlight the crucial role of extracellular vesicles (EVs) in mediating miRNA regula...

    Authors: Zhihui Dai, Li Lin, Yanan Xu, Lifang Hu, Shiping Gou and Xinkai Xu
    Citation: BMC Pulmonary Medicine 2024 24:173
  45. Bronchiectasis is a pulmonary disease characterized by irreversible dilation of the bronchi and recurring respiratory infections. Few studies have described the microbiology and prevalence of infections in lar...

    Authors: Samantha G Dean, Rebekah A Blakney, Emily E Ricotta, James D Chalmers, Sameer S Kadri, Kenneth N Olivier and D Rebecca Prevots
    Citation: BMC Pulmonary Medicine 2024 24:172
  46. Autoimmune pulmonary alveolar proteinosis (APAP) is a diffuse lung disease that causes abnormal accumulation of lipoproteins in the alveoli; however, its pathogenesis remains unclear. Recently, APAP cases have...

    Authors: Masakiyo Yatomi, Keiichi Akasaka, Shintaro Sato, Mizuki Chida, Mio Kanbe, Hiru Sawada, Itaru Yokota, Ikuo Wakamatsu, Sohei Muto, Mari Sato, Kochi Yamaguchi, Yosuke Miura, Hiroaki Tsurumaki, Reiko Sakurai, Kenichiro Hara, Yasuhiko Koga…
    Citation: BMC Pulmonary Medicine 2024 24:170
  47. The association of physical activity (PA) and lung function (LF) varies from no measurable effect to delayed LF decline. We assessed the association between accelerometery-assessed PA and LF in a sample of app...

    Authors: Sybile Collaud, Brice Touilloux, Christophe von Garnier, Pedro Marques-Vidal and Vanessa Kraege
    Citation: BMC Pulmonary Medicine 2024 24:169

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal